4//SEC Filing
Myers C. Daniel 4
Accession 0001415889-23-010289
CIK 0001479419other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 8:00 PM ET
Size
12.0 KB
Accession
0001415889-23-010289
Insider Transaction Report
Form 4
Myers C. Daniel
Director
Transactions
- Award
Common Stock
2023-06-22+1,100→ 6,524 total - Award
Stock Option (right to buy)
2023-06-22+5,046→ 5,046 totalExercise: $14.56Exp: 2033-06-21→ Common Stock (5,046 underlying) - Award
Stock Option (right to buy)
2023-06-22+2,500→ 2,500 totalExercise: $14.56Exp: 2033-06-21→ Common Stock (2,500 underlying) - Award
Common Stock
2023-06-22+3,784→ 5,424 total
Footnotes (6)
- [F1]Grant of restricted stock units ("RSUs") under the Issuer's Amended and Restated 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued service, the RSUs will vest as to 1/3 of the shares underlying the RSUs on June 22, 2024, as to 1/3 of the shares underlying the RSUs on June 22, 2025 and as to the final 1/3 of shares underlying the RSUs on June 22, 2026.
- [F2]Includes 5,424 unvested RSUs.
- [F3]Grant of RSUs under the Issuer's Amended and Restated 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued service, the RSUs will vest as to 100% of the shares underlying the grant on the earlier of (i) June 22, 2024 or (ii) the date of the first annual meeting following June 22, 2023.
- [F4]Includes 6,524 unvested RSUs.
- [F5]This option was granted on June 22, 2023 and vests over four years beginning on the vesting commencement date of June 22, 2023, with 25% of the shares underlying the option vesting on June 22, 2024, and an additional 1/48th the shares underlying the option vesting at the end of each successive one-month period thereafter.
- [F6]This option was granted on June 22, 2023 and vests as to 100% of the shares underlying the grant on the earlier of (i) June 22, 2024 or (ii) the date of the first annual meeting following June 22, 2023.
Documents
Issuer
Kala Pharmaceuticals, Inc.
CIK 0001479419
Entity typeother
Related Parties
1- filerCIK 0001489533
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 8:00 PM ET
- Size
- 12.0 KB